FREDRIC N ESHELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of FREDRIC N ESHELMAN
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.54 | 5,000 | 167,700 | 9,272,293 | 9.3 M to 9.3 M (-0.05 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.53 | 300 | 10,059 | 9,277,293 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.52 | 2,600 | 87,152 | 9,277,593 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.51 | 1,700 | 56,967 | 9,280,193 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.50 | 1,100 | 36,850 | 9,281,893 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.49 | 9,433 | 315,911 | 9,282,993 | 9.3 M to 9.3 M (-0.10 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.48 | 6,900 | 231,012 | 9,292,426 | 9.3 M to 9.3 M (-0.07 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.47 | 1,400 | 46,858 | 9,299,326 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.46 | 700 | 23,422 | 9,300,726 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.45 | 200 | 6,690 | 9,301,426 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.44 | 300 | 10,032 | 9,301,626 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.43 | 500 | 16,715 | 9,301,926 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.42 | 1,900 | 63,498 | 9,302,426 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.41 | 1,400 | 46,774 | 9,304,326 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.40 | 3,900 | 130,260 | 9,305,726 | 9.3 M to 9.3 M (-0.04 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.39 | 2,528 | 84,410 | 9,309,626 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.38 | 8,272 | 276,119 | 9,312,154 | 9.3 M to 9.3 M (-0.09 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.37 | 8,600 | 286,982 | 9,320,426 | 9.3 M to 9.3 M (-0.09 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.36 | 4,000 | 133,440 | 9,329,026 | 9.3 M to 9.3 M (-0.04 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.35 | 2,600 | 86,710 | 9,333,026 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.34 | 2,500 | 83,350 | 9,335,626 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.33 | 600 | 19,998 | 9,338,126 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.32 | 1,513 | 50,413 | 9,338,726 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.31 | 987 | 32,877 | 9,340,239 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.30 | 500 | 16,650 | 9,341,226 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.29 | 2,900 | 96,541 | 9,341,726 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.28 | 1,500 | 49,920 | 9,344,626 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.27 | 829 | 27,581 | 9,346,126 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.26 | 384 | 12,772 | 9,346,955 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.25 | 687 | 22,843 | 9,347,339 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.24 | 300 | 9,972 | 9,348,026 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.23 | 600 | 19,938 | 9,348,326 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.22 | 100 | 3,322 | 9,348,926 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.21 | 400 | 13,284 | 9,349,026 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.20 | 800 | 26,560 | 9,349,426 | 9.4 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.19 | 400 | 13,276 | 9,350,226 | 9.4 M to 9.4 M (0.00 %) |
| Feb 23 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | A | 33.61 | 50,000 | 1,680,500 | 50,000 | |
| Dec 18 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Gift | G | 0.00 | 74,492 | 0 | 9,350,626 | 9.4 M to 9.4 M (-0.79 %) |
| May 19 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Payment of Exercise | F | 35.96 | 5,408 | 194,472 | 9,425,118 | 9.4 M to 9.4 M (-0.06 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 1,614 | 59,202 | 9,442,706 | 9.4 M to 9.4 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.67 | 3,836 | 140,666 | 9,444,320 | 9.4 M to 9.4 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.66 | 424 | 15,544 | 9,448,156 | 9.4 M to 9.4 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.65 | 2,660 | 97,489 | 9,448,580 | 9.5 M to 9.4 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.64 | 1,245 | 45,617 | 9,451,240 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.63 | 384 | 14,066 | 9,452,485 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.62 | 4,100 | 150,142 | 9,452,869 | 9.5 M to 9.5 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.61 | 1,500 | 54,915 | 9,456,969 | 9.5 M to 9.5 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.60 | 2,240 | 81,984 | 9,458,469 | 9.5 M to 9.5 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.59 | 200 | 7,318 | 9,460,709 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.58 | 100 | 3,658 | 9,460,909 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.57 | 700 | 25,599 | 9,461,009 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.56 | 400 | 14,624 | 9,461,709 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.55 | 2,599 | 94,993 | 9,462,109 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.54 | 9,300 | 339,822 | 9,464,708 | 9.5 M to 9.5 M (-0.10 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.53 | 376 | 13,735 | 9,474,008 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.52 | 800 | 29,216 | 9,474,384 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.51 | 4,584 | 167,362 | 9,475,184 | 9.5 M to 9.5 M (-0.05 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.50 | 4,910 | 179,215 | 9,479,768 | 9.5 M to 9.5 M (-0.05 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.49 | 800 | 29,192 | 9,484,678 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.48 | 2,547 | 92,915 | 9,485,478 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.47 | 3,797 | 138,477 | 9,488,025 | 9.5 M to 9.5 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.46 | 1,307 | 47,653 | 9,491,822 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.45 | 3,326 | 121,233 | 9,493,129 | 9.5 M to 9.5 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.44 | 2,673 | 97,404 | 9,496,455 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.43 | 1,071 | 39,017 | 9,499,128 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.42 | 2,682 | 97,678 | 9,500,199 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.41 | 500 | 18,205 | 9,502,881 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.40 | 2,000 | 72,800 | 9,503,381 | 9.5 M to 9.5 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.38 | 100 | 3,638 | 9,505,381 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 1,300 | 48,100 | 9,430,526 | 9.4 M to 9.4 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.75 | 300 | 11,025 | 9,431,826 | 9.4 M to 9.4 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.74 | 800 | 29,392 | 9,432,126 | 9.4 M to 9.4 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.73 | 300 | 11,019 | 9,432,926 | 9.4 M to 9.4 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.72 | 1,380 | 50,674 | 9,433,226 | 9.4 M to 9.4 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.71 | 1,500 | 55,065 | 9,434,606 | 9.4 M to 9.4 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.70 | 4,100 | 150,470 | 9,436,106 | 9.4 M to 9.4 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.69 | 2,500 | 91,725 | 9,440,206 | 9.4 M to 9.4 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.37 | 300 | 10,911 | 9,505,481 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.35 | 100 | 3,635 | 9,505,781 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.34 | 2,400 | 87,216 | 9,505,881 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.33 | 1,400 | 50,862 | 9,508,281 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.32 | 2,600 | 94,432 | 9,509,681 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.31 | 1,200 | 43,572 | 9,512,281 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.30 | 400 | 14,520 | 9,513,481 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.29 | 324 | 11,758 | 9,513,881 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.28 | 8,716 | 316,216 | 9,514,205 | 9.5 M to 9.5 M (-0.09 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.27 | 600 | 21,762 | 9,522,921 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.26 | 9,684 | 351,142 | 9,523,521 | 9.5 M to 9.5 M (-0.10 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.25 | 2,980 | 108,025 | 9,533,205 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.24 | 194 | 7,031 | 9,536,185 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.23 | 300 | 10,869 | 9,536,379 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.22 | 411 | 14,886 | 9,536,679 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.21 | 1,358 | 49,173 | 9,537,090 | 9.5 M to 9.5 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.20 | 3,197 | 115,731 | 9,538,448 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.19 | 200 | 7,238 | 9,541,645 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.18 | 2,704 | 97,831 | 9,541,845 | 9.5 M to 9.5 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.17 | 200 | 7,234 | 9,544,549 | 9.5 M to 9.5 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.16 | 3,400 | 122,944 | 9,544,749 | 9.5 M to 9.5 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.15 | 5,525 | 199,729 | 9,548,149 | 9.6 M to 9.5 M (-0.06 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.14 | 9,398 | 339,644 | 9,553,674 | 9.6 M to 9.6 M (-0.10 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.13 | 3,926 | 141,846 | 9,563,072 | 9.6 M to 9.6 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.12 | 1,981 | 71,554 | 9,566,998 | 9.6 M to 9.6 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.11 | 3,000 | 108,330 | 9,568,979 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.10 | 2,047 | 73,897 | 9,571,979 | 9.6 M to 9.6 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.09 | 600 | 21,654 | 9,574,026 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.08 | 2,800 | 101,024 | 9,574,626 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.07 | 100 | 3,607 | 9,577,426 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.02 | 2,928 | 108,395 | 9,577,526 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.01 | 521 | 19,282 | 9,580,454 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 300 | 11,100 | 9,580,975 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.99 | 409 | 15,129 | 9,581,275 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.98 | 3,000 | 110,940 | 9,581,684 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.97 | 7,900 | 292,063 | 9,584,684 | 9.6 M to 9.6 M (-0.08 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.96 | 3,300 | 121,968 | 9,592,584 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.95 | 200 | 7,390 | 9,595,884 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.94 | 10,200 | 376,788 | 9,596,084 | 9.6 M to 9.6 M (-0.11 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.93 | 2,781 | 102,702 | 9,606,284 | 9.6 M to 9.6 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.92 | 20,795 | 767,751 | 9,609,065 | 9.6 M to 9.6 M (-0.22 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.91 | 1,041 | 38,423 | 9,629,860 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.89 | 1,000 | 36,890 | 9,630,901 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.88 | 200 | 7,376 | 9,631,901 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.87 | 92 | 3,392 | 9,632,101 | 9.6 M to 9.6 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.83 | 3,488 | 128,463 | 9,632,193 | 9.6 M to 9.6 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.82 | 600 | 22,092 | 9,635,681 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.81 | 1,600 | 58,896 | 9,636,281 | 9.6 M to 9.6 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.80 | 1,200 | 44,160 | 9,637,881 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.79 | 711 | 26,158 | 9,639,081 | 9.6 M to 9.6 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.78 | 14,040 | 516,391 | 9,639,792 | 9.7 M to 9.6 M (-0.15 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.77 | 172 | 6,324 | 9,653,832 | 9.7 M to 9.7 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.76 | 1,288 | 47,347 | 9,654,004 | 9.7 M to 9.7 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.75 | 2,100 | 77,175 | 9,655,292 | 9.7 M to 9.7 M (-0.02 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.74 | 6,099 | 224,077 | 9,657,392 | 9.7 M to 9.7 M (-0.06 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.73 | 1,340 | 49,218 | 9,663,491 | 9.7 M to 9.7 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.72 | 4,659 | 171,078 | 9,664,831 | 9.7 M to 9.7 M (-0.05 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.71 | 1,096 | 40,234 | 9,669,490 | 9.7 M to 9.7 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.70 | 19,309 | 708,640 | 9,670,586 | 9.7 M to 9.7 M (-0.20 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.69 | 12,500 | 458,625 | 9,689,895 | 9.7 M to 9.7 M (-0.13 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 861 | 31,581 | 9,702,935 | 9.7 M to 9.7 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.67 | 43,809 | 1,606,476 | 9,703,256 | 9.7 M to 9.7 M (-0.45 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.66 | 59,079 | 2,165,836 | 9,747,065 | 9.8 M to 9.7 M (-0.60 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.65 | 3,385 | 124,060 | 9,806,144 | 9.8 M to 9.8 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.64 | 6,800 | 249,152 | 9,809,529 | 9.8 M to 9.8 M (-0.07 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.63 | 385 | 14,103 | 9,816,329 | 9.8 M to 9.8 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.62 | 3,821 | 139,925 | 9,816,714 | 9.8 M to 9.8 M (-0.04 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.61 | 908 | 33,242 | 9,820,535 | 9.8 M to 9.8 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.53 | 83 | 3,032 | 9,821,443 | 9.8 M to 9.8 M (0.00 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.52 | 2,799 | 102,219 | 9,821,526 | 9.8 M to 9.8 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.49 | 3,300 | 120,417 | 9,824,325 | 9.8 M to 9.8 M (-0.03 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.48 | 1,300 | 47,424 | 9,827,625 | 9.8 M to 9.8 M (-0.01 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.45 | 1,601 | 58,356 | 9,828,925 | 9.8 M to 9.8 M (-0.02 %) |